BF Biosciences Statistics

Total Valuation

BF Biosciences has a market cap or net worth of PKR 12.50 billion. The enterprise value is 13.33 billion.

Market Cap	12.50B
Enterprise Value	13.33B

Important Dates

The last earnings date was Monday, April 27, 2026.

Earnings Date	Apr 27, 2026
Ex-Dividend Date	n/a

Share Statistics

BF Biosciences has 88.33 million shares outstanding. The number of shares has increased by 18.28% in one year.

Current Share Class	88.33M
Shares Outstanding	88.33M
Shares Change (YoY)	+18.28%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.13%
Float	25.00M

Valuation Ratios

The trailing PE ratio is 21.13.

PE Ratio	21.13
Forward PE	n/a
PS Ratio	1.41
PB Ratio	2.44
P/TBV Ratio	2.44
P/FCF Ratio	n/a
P/OCF Ratio	42.05
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.62, with an EV/FCF ratio of -61.55.

EV / Earnings	22.53
EV / Sales	1.50
EV / EBITDA	10.62
EV / EBIT	13.52
EV / FCF	-61.55

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.34.

Current Ratio	1.99
Quick Ratio	0.64
Debt / Equity	0.34
Debt / EBITDA	1.37
Debt / FCF	-7.96
Interest Coverage	8.55

Financial Efficiency

Return on equity (ROE) is 12.25% and return on invested capital (ROIC) is 10.69%.

Return on Equity (ROE)	12.25%
Return on Assets (ROA)	7.11%
Return on Invested Capital (ROIC)	10.69%
Return on Capital Employed (ROCE)	14.39%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	16.56M
Profits Per Employee	1.11M
Employee Count	535
Asset Turnover	1.02
Inventory Turnover	2.24

Taxes

In the past 12 months, BF Biosciences has paid 428.67 million in taxes.

Income Tax	428.67M
Effective Tax Rate	42.01%

Stock Price Statistics

The stock price has decreased by -6.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.67%
50-Day Moving Average	143.58
200-Day Moving Average	155.34
Relative Strength Index (RSI)	46.27
Average Volume (20 Days)	233,552

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BF Biosciences had revenue of PKR 8.86 billion and earned 591.76 million in profits. Earnings per share was 6.70.

Revenue	8.86B
Gross Profit	3.74B
Operating Income	986.10M
Pretax Income	1.02B
Net Income	591.76M
EBITDA	1.26B
EBIT	986.10M
Earnings Per Share (EPS)	6.70

Full Income Statement

Balance Sheet

The company has 895.05 million in cash and 1.72 billion in debt, giving a net cash position of -828.77 million or -9.38 per share.

Cash & Cash Equivalents	895.05M
Total Debt	1.72B
Net Cash	-828.77M
Net Cash Per Share	-9.38
Equity (Book Value)	5.13B
Book Value Per Share	57.96
Working Capital	2.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 297.30 million and capital expenditures -513.91 million, giving a free cash flow of -216.61 million.

Operating Cash Flow	297.30M
Capital Expenditures	-513.91M
Depreciation & Amortization	268.99M
Net Borrowing	-483.80M
Free Cash Flow	-216.61M
FCF Per Share	-2.45

Full Cash Flow Statement

Margins

Gross margin is 42.19%, with operating and profit margins of 11.13% and 6.68%.

Gross Margin	42.19%
Operating Margin	11.13%
Pretax Margin	11.52%
Profit Margin	6.68%
EBITDA Margin	14.17%
EBIT Margin	11.13%
FCF Margin	n/a

Dividends & Yields

BF Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.28%
Shareholder Yield	-18.28%
Earnings Yield	4.73%
FCF Yield	-1.73%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6